2,2′:6′,2″-Terpyridine[hydroxypropyl-β-cyclodextr in] 1:3 complex used as chelating agent for the determination of iron with a sensitive, selective and fast liquid chromatographic method

Analytica Chimica Acta

Volumn 566, Issue 1, 2006, Pages 122-129

  Mytides, Panos ^a   Rozou, Stavroula ^b   Benaki, Dimitra ^c   Antoniadou Vyza, Ekaterini ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ELPEN Pharmaceuticals   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

2,2 :6 ,2 Terpyridine; Chelate agent; Cyclodextrin complex; Iron; Liquid chromatography; NMR

Indexed keywords

ABSORPTION; CHELATION; DRUG PRODUCTS; IRON; LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; POSITIVE IONS; SUPRAMOLECULAR CHEMISTRY;

2,2′:6′,2″-TERPYRIDINE; CHELATE AGENT; CYCLODEXTRIN COMPLEX;

ORGANIC COMPOUNDS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2,2':6',2'' TERPYRIDINE[HYDROXYPROPYL BETA CYCLODEXTRIN] 1:3 COMPLEX; BETA CYCLODEXTRIN DERIVATIVE; CHELATING AGENT; COBALT; CUPRIC ION; FERRIC ION; FERROUS ION; NICKEL; PYRIDINE DERIVATIVE; REAGENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; CHELATION; COMPLEX FORMATION; DRUG DETERMINATION; DRUG FORMULATION; LIQUID CHROMATOGRAPHY; MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STOICHIOMETRY;

EID: 33646473395     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2006.02.067     Document Type: Article

References (22)

1. Cotton A., and Wilkinson G. The Biochemistry of Iron in Advanced Inorganic Chemistry. 5th ed. (1988), Wiley Interscience, USA p. 1336
2. Martindale, 33th ed., Pharmaceutical press, London UK, 2002, pp. 1366-1369
3. Raggi M.A., Nobile L., and Ramini M. Int. J. Pharm. 61 (1990) 199
4. Gui-Fa Y., Guo-Rong S., and Yi-Ming L. Anal. Chim. Acta 264 (1992) 121
5. Canfranc E., Abarca A., Sierra I., and Marina M.L. J. Pharm. Biomed. Anal. 25 (2001) 103
6. Paleologos E.K., Giokas D.L., Tzouwara-Karayanni S.M., and Karayiannis M.I. Anal. Chim. Acta 458 (2002) 241
7. Niemela M., Kol H., Eilola K., and Deramaki P. J. Pharm. Biomed. Anal. 35 (2004) 433
8. Dahlen J., and Karlsson S. J. Chromatogr. A 848 (1999) 491
9. Ostrakh M.I., Milder O.B., and Semionkin V.A. Anal. Chim. Acta 506 (2004) 155
10. Hoshino H., Nomura T., Nakano K., and Yotsuyanagi T. Anal. Chem. 68 (1996) 1960
11. Dahlen J., and Karlsson S. J. Chromatogr. A 848 (1999) 491
12. Uekama K., and Hirayama F. Improvement of drug properties by cyclodextrins. The Pratice of Medicinal Chem (1996), Academic Press pp. 809-810
13. Rozou S., and Antoniadou-Vyza E. J. Pharm. Biomed. Anal. 18 (1998) 899
14. Zouvelekis D., Yannakopoulou K., Mavridis I., and Antoniadou-Vyza E. Carbohyd. Res. 337 (2002) 1387
15. Rozou S., Michaleas S., and Antoniadou-Vyza E. Chromatographia 57 (2003) 81
16. Rozou S., Voulgari A., and Antoniadou-Vyza E. Eur. J. Pharm. Sci. 21 (2004) 661
17. Rozou S., and Antoniadou-Vyza E. J. Chromatogr. A 1041 (2004) 187
18. Djedaini F., and Perly B. NMR of cyclodextrins, derivatives and inclusion complexes. The Ultimate Tool in New Trends in cyclodextrins and derivatives (1991), de Sante pp. 226-228
19. Schneider H.-J., Hacket F., Rudiger V., and Ikeda H. Chem. Rev. 98 (1998) 1755
20. Liu Y., Li L., Zhang H.-Y., Yang Y.-W., and Ding F. Supramol. Chem. 16 (2004) 371
21. Redondo J., Blazques M.A., and Torrens A. Chirality 11 (1999) 694
22. Amouyal E., and Mouallem-Bahout M. J. Chem. Soc. Dalton Trans. (1992) 509